Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kaye Randall
Relationship:   CMO
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   88,632    

Indirect Shares

   18,522      
Direct Value   $380,065    

Indirect Value

   $455,745      
Total Shares   107,154      
Total Value   $835,810      


Avanir Pharmaceuticals $0 Axsome Therapeutics, Inc. $380,065 Longboard Pharmaceuticals, Inc. $0 Avanir Pharmaceuticals $0 Axsome Therapeutics, Inc. $380,065 Longboard Pharmaceuticals, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avanir Pharmaceuticals AVNR Sr. VP, Chief Medical ... 2011-09-09 65,690 2011-09-09 12,500    Premium*  
            Axsome Therapeutics, Inc. AXSM Chief Medical Officer 2015-11-24 5,022 2015-12-23 6,022    Premium*  
            Longboard Pharmaceuticals, Inc. LBPH CMO 2024-02-08 17,920 2024-02-08 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LBPH Longboard Pharmaceuticals... CMO   •       –      –    2024-02-08 4 A $0.00 $0 D/D 17,920 17,920 0 -
AXSM Axsome Therapeutics, Inc. Chief Medical Officer   •       –      –    2015-12-23 4 B $9.03 $9,026 I/I 1,000 6,022 1.99 -
AXSM Axsome Therapeutics, Inc. Chief Medical Officer   •       –      –    2015-11-24 4 OE $5.40 $27,119 D/D 5,022 5,022 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2011-09-09 4 AS $2.75 $275,000 D/D (100,000) 65,690 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2011-01-05 4 AS $4.05 $40,500 D/D (10,000) 165,690 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-12-13 4 D $3.92 $5,668 D/D (1,446) 175,690 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-12-06 4 AS $3.80 $38,000 D/D (10,000) 177,136 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-12-01 4 A $0.00 $0 D/D 17,500 196,836 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-11-05 4 AS $4.76 $47,556 D/D (10,000) 187,136 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-10-05 4 AS $3.23 $32,269 D/D (10,000) 227,036 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-09-13 4 D $2.70 $3,907 D/D (1,447) 237,036 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-09-07 4 AS $2.70 $27,034 D/D (10,000) 238,483 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-08-18 4 S $3.08 $107,664 D/D (35,000) 248,483 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-08-05 4 AS $3.28 $32,800 D/D (10,000) 283,483 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-07-07 4 AS $3.02 $30,203 D/D (10,000) 293,483 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-06-13 4 D $2.71 $3,921 D/D (1,447) 303,483 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-06-07 4 AS $2.38 $119,115 D/D (50,000) 304,930 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-03-13 4 D $2.13 $3,084 D/D (1,448) 354,930 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-01-04 4/A D $1.97 $55,316 I/I (28,079) 368,878 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2010-01-04 4 D $1.97 $56,143 I/I (28,499) 368,458 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2009-12-13 4 D $1.82 $2,457 I/I (1,350) 396,957 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2009-09-15 4 S $2.10 $4,200 I/I (2,000) 398,307 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2009-09-13 4 D $2.21 $2,981 I/I (1,349) 400,307 0 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2009-09-11 4 B $2.18 $4,360 I/I 2,000 401,656 1.91 -
AVNR Avanir Pharmaceuticals Sr. VP, Chief Medical Officer   •       –      –    2009-07-15 4 D $2.13 $49,895 I/I (23,425) 399,656 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us